A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J. van der Lee, Estrella Morenas‐Rodríguez, RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia) et al.|Acta Neuropathologica|2019Cited by 132